The LolCDE complex is an ATP-binding cassette transporter that mediates the release of newly synthesized lipoproteins from the cytoplasmic membrane of gram-negative bacteria, which results in the initiation of outer-membrane sorting of lipoproteins through the Lol pathway. LolCDE is composed of one copy each of membrane subunits LolC and LolE, and two copies of nucleotide-binding subunit LolD. In this study, we examined the membrane topology of LolC and LolE by PhoA fusion analysis. Both LolC and LolE were found to have four transmembrane segments with a large periplasmic loop exposed to the periplasm. Despite similarities in sequence and topology, the accessibility of a sulfhydryl reagent to Cys introduced into the periplasmic loop suggested that the structure of the periplasmic region differs between LolC and LolE. Inhibition of the release of lipoproteins by the sulfhydryl reagent supported a previous proposal that LolC and LolE have distinct functions.
The LolCDE complex is an ATP-binding cassette transporter that mediates the release of newly synthesized lipoproteins from the cytoplasmic membrane of gram-negative bacteria, which results in the initiation of outer-membrane sorting of lipoproteins through the Lol pathway. LolCDE is composed of one copy each of membrane subunits LolC and LolE, and two copies of nucleotide-binding subunit LolD. In this study, we examined the membrane topology of LolC and LolE by PhoA fusion analysis. Both LolC and LolE were found to have four transmembrane segments with a large periplasmic loop exposed to the periplasm. Despite similarities in sequence and topology, the accessibility of a sulfhydryl reagent to Cys introduced into the periplasmic loop suggested that the structure of the periplasmic region differs between LolC and LolE. Inhibition of the release of lipoproteins by the sulfhydryl reagent supported a previous proposal that LolC and LolE have distinct functions.
Key words: ATP binding cassette (ABC) transporter; lipoprotein; membrane topology; PhoA fusion; sulfhydryl reagent ATP-binding cassette (ABC) transporters mediate the transport of a wide variety of substrates across the membranes of eukaryotes, archaea, and eubacteria. 1) ABC transporters are generally composed of two transmembrane domains and two nucleotide-binding domains. The nucleotide-binding domains generate energy for transport through binding and hydrolysis of ATP, whereas the transmembrane domains are involved in the binding and transport of substrates across membranes. The four domains of bacterial ABC transporters frequently reside in separate polypeptides.
2) The structures of some ABC transporter complexes have been solved by X-ray crystallography. 1) Among them, only MalFGK 2 of Escherichia coli is composed of heterogeneous transmembrane subunits, MalF and MalG. 3) MalFGK 2 together with a periplasmic maltose-binding protein (MBP) mediates the uptake of maltose. The structures and functions of MalF and MalG differ significantly. MalF comprises 514 amino acid residues and eight transmembrane segments (TMSs), while MalG comprises 296 amino acid residues and six TMSs. Moreover, MalF binds to maltose, while MBP initially targets MalG. 3, 4) Like MalFGK 2 , LolCDE of E. coli is composed of a heterodimer of transmembrane subunits LolC and LolE, and a homodimer of nucleotide-binding subunit LolD. 5) LolCDE catalyzes a unique reaction, the membranedetachment of lipoproteins, membrane proteins possessing a lipid-attached Cys at the N-terminus. Lipoprotein precursors are translocated across the cytoplasmic membrane by a Sec translocon and then are processed to mature forms on the outer surface of the cytoplasmic membrane. 6, 7) In gram-negative bacteria, lipoproteins having outer-membrane sorting signals are released from the cytoplasmic membrane by LolCDE, resulting in the formation of a complex with LolA, a periplasmic carrier protein. The LolA-lipoprotein complex then crosses the periplasm to reach the outer membrane, where LolB is present and mediates the transfer of lipoproteins from LolA to the outer membrane, the final destination. 8, 9) A single cycle of the lipoprotein transfer from LolCDE to LolA was examined with a novel liganded LolCDE, and it revealed detailed molecular events occurring upon the binding and hydrolysis of ATP. 10) The lipoprotein transfer reaction accompanies the opening of the hydrophobic cavity of LolA.
11) It has been proposed that ATP hydrolysis by LolD induces a conformational change of LolC and/or LolE, which is then utilized to open the hydrophobic cavity of LolA.
In contrast to MalF and MalG, the amino aid sequences and predicted membrane topologies of LolC and LolE are very similar to each other. 5) LolC and LolE comprise 399 and 414 amino acid residues respectively, share 26% sequence identity, and are predicted to span the membrane 4 times with a large region exposed to the periplasm. Both LolC and LolE are essential for E. coli growth. 12) On the other hand, the lipoprotein-releasing activity can be reconstituted into proteoliposomes with LolE and LolD but without LolC. 13) More recently, it was found that LolA interacts with LolC but not LolE. 14) These observations taken together indicate that LolC y To whom correspondence should be addressed. Tel: +81-3-5841-7832; Fax: +81-3-5841-8464; E-mail: narita@iam.u-tokyo.ac.jp Abbreviations: ABC, ATP binding cassette; AMS, 4-acetoamide-4 0 -maleimidylstilbene-2,2 0 -disulfonic acid; NEM, N-ethylmaleimide; TMS, transmembrane segment and LolE play different roles in the lipoprotein transfer reaction despite their structural resemblance.
ABC transporters generally have more than 10 transmembrane segments (TMSs). On the other hand, a small number of ABC transporters, such as LolCDE and MacB, have been predicted to have membrane subunits with four TMSs. 15) A large periplasmic domain between TMS-1 and TMS-2 is characteristic of these four TMS membrane subunits. 15) MacB was reported to be involved in the export of heat-stable enterotoxin after it had been translocated across the inner membrane by the Sec machinery. 16) Thus, neither LolCDE nor MacB catalyzes the trans-membrane movement of substrates, as for other ABC transporters. Both LolCDE and MacB require periplasmic factors for the transport of substrates, viz., LolA for LolCDE and MacA and TolC for MacB. The periplasmic regions of these ABC transporters are hence expected to be functionally important.
Here we determined the membrane topologies of LolC and LolE and examined the functional importance of their periplasmic regions. 0 -maleimidylstilbene-2,2 0 -disulfonic acid (AMS) was from Molecular Probes (Eugene, OR, USA). LolA was purified from E. coli TT016 cells harboring pAM201, as described previously. 17) Anti-PhoA antibodies were purchased from Sigma.
Materials and Methods

Materials
Bacterial strains and media. Escherichia coli K-12 strains DLP79-36 18) and CDE4 12) were used. E. coli cells were grown on LB 19) or M63 (NaCl)-maltose. 20) When necessary, ampicillin and chloramphenicol were added to the medium at 50 and 35 mg/ml respectively.
Plasmids. Series of plasmids encoding LolC and LolE fused to alkaline phosphatase (PhoA; mol. mass ¼ 47 kDa) were constructed as follows (Supplemental Fig. 1 ; see Biosci. Biotechnol. Biochem. Web site). DNA fragments encoding LolC, LolE, and the mature region of PhoA were amplified from chromosomal DNA of E. coli MC4100 21) using primer pairs LolC-N-F plus LolC-PstI, LolE-N-F plus LolE-PstI, and phoA-PstI plus phoA-HindIII respectively (Supplemental Table 1 ; see Biosci. Biotechnol. Biochem. Web site). The amplified lolC gene was digested with EcoRI and PstI, mixed with phoA digested with PstI and HindIII, and then cloned into the EcoRI-HindIII sites of pMAN885EH 20) to construct pMAN885EH-lolC-phoA. Likewise, the lolE gene was digested with EcoRI and PstI, mixed with PstI-HindII digested phoA, and then cloned into the EcoRI-HindIII sites of pMAN885EH to construct pMAN885EH-lolE-phoA. Plasmids encoding LolC-PhoA fusions were then constructed by PCR with lolCnBglII (where ''n'' indicates the position of LolC fused to PhoA) and phoA0214 (Supplemental Table 1 ) as primers and pMAN885EH-lolCphoA as a template, followed by BglII digestion and self ligation. Plasmids encoding LolE-PhoA fusions were also constructed by PCR with lolEn-BglII and phoA0214 as primers and pMAN885EH-lolEphoA as template. Plasmids encoding LolC and ones encoding LolE derivatives having a single Cys were constructed on a plasmid that encodes LolC, LolD, and Cys-less LolE. To this end, an EcoRIHindIII fragment of pKM401 22) was cloned into the same sites of pMAN885EH bearing pAICDE. Two codons encoding Cys of LolE were then replaced by ones encoding Ser with a QuikChange sitedirected mutagenesis kit (Stratagene, La Jolla, CA, USA) according to the manufacturer's protocol using pAICDE as a template to construct pCYSE0 (primer sequences available upon request). Subsequently, site-directed mutagenesis of pCYSE0 was carried out again to introduce Cys into LolC or LolE. A plasmid, pMYL10P, encoding L10P, a derivative of the major outer membrane lipoprotein Lpp, under the control of the lac promoter was constructed by subcloning of the EcoRI-SalI fragment of pJYL10P 23) into pUC19.
24)
Preparation of anti-LolC, -LolE, and -Lpp antibodies. Anti-LolC and -LolE antibodies were raised in rabbits against their periplasmic regions. A DNA fragment encoding a polypeptide corresponding to the 48-268 region of LolC and one corresponding to the 47-273 region of LolE with a hexahistidine-tag at the C-terminus were amplified by PCR using primers pLolC-3N and pLolC-3C for LolC, and pLolE-5N and pLolE-5C for LolE (Supplemental Table 1 ) with pKM401 as template. The amplified fragments were digested with NdeI and AvaI, and then respectively cloned into the same sites of pIVEX2.3 MCS (Roche, Penzberg, Germany). The resulting plasmids were used as templates for the in vitro transcription/translation system (RTS 500, Roche). His-tagged polypeptides were then purified by chromatography on TALON metal affinity resin (Clontech, Mountain View, CA, USA), and were used to immunize the rabbits.
A DNA fragment encoding the mature region of Lpp with a hexahistidine-tag at the N-terminus was amplified from the chromosomal DNA of MC4100 by PCR using primers His-lpp-1 and His-lpp-2 (Supplemental Table 1 ), digested with NotI, and then cloned into the SmaI-NotI sites of pIVEX2.4c (Roche). His-tagged Lpp was synthesized in vitro by the RTS 500 system, purified with TALON resin, and used to immunize a rabbit.
Measurement of PhoA activity. PhoA activity was determined by measuring the hydrolysis of p-nitrophenyl phosphate in cells permeabilized by treatment with CHCl 3 and SDS at 37 C, as described by Manoil.
25) DLP79-36 cells harboring a plasmid encoding a LolC-PhoA or LolE-PhoA fusion were grown in LB. When the absorbance at 660 nm (A 660 ) of the culture reached 0.4, expression of PhoA fusions was induced for 1 h by the addition of 0.1% arabinose. The cell pellets were washed once with 10 mM Tris-HCl, pH 8.0, containing 10 mM MgSO 4 , and then resuspended in 1 mM Tris-HCl, pH 8.0. After measurement of the cell density at A 600 , the cell suspensions (0.1 ml) were diluted with 0.9 ml of 1 mM Tris-HCl, pH 8.0, containing 0.1 mM ZnCl 2 , and then mixed with 50 ml each of 0.1% SDS and CHCl 3 . The permeabilized cells were incubated for 20 min at 37 C with 0.1 ml of 1 mM Tris-HCl containing 0.4% p-nitrophenyl phosphate. The A 420 and A 550 of the reaction mixture were measured, and PhoA activity was calculated according to the following equation: PhoA activity ¼ 1; 000 Â ½A 420 À ð1:75 Â A 550 Þ=½t Â vol Â A 600 , where t is the time (min) of incubation and vol is the volume of culture used in the assay (ml).
Chemical labeling of Cys in LolC and LolE. CDE4 cells harboring pCYSE0 derivatives and pMYL10P were grown in M63 medium containing 0.001% arabinose at 30 C. When the A 660 of the culture reached 0.8, expression of L10P was induced for 5 min by the addition of 1 mM isopropyl-1-thio--D-galactopyranoside. The cells were harvested and converted into spheroplasts as previously described. 26) Aliquots (300 ml) of suspensions containing 5 Â 10 8 spheroplasts were incubated at 30 C for 5 min in the presence and the absence of 5 mM AMS. The reaction was terminated by the addition of 750 ml of 50 mM Tris-HCl, pH 7.5, containing 10 mM 2-mercaptoethanol and 62.5 mg/ml DNase I, and chilling on ice. The spheroplasts were disrupted by sonication, and membrane fractions were collected by ultracentrifugation at 100;000 Â g for 1 h, washed once with 50 mM Tris-HCl, pH 7.5, and then resuspended in 27 ml of 50 mM MOPS-KOH, pH 7.0, containing 0.1 M KCl.
14 C-NEM (3 ml of 6.25 mM, 1.2284 GBq/mmol) was added to the suspension, followed by incubation for 1 h at 25 C. The reaction was terminated by the addition of 270 ml of the same buffer containing 5 mM unlabeled NEM and chilling on ice. After trichloroacetic acid precipitation, LolC and LolE were immunoprecipitated with anti-LolC and anti-LolE antibodies respectively, as reported previously, 27) and detected by SDS-PAGE, followed by phosphorimaging using STORM 820 (GE Healthcare) or immunoblotting with anti-LolC and anti-LolE antibody respectively.
Lipoprotein-releasing assay from spheroplasts. Spheroplasts expressing LolCDE with a Cys-containing subunit were prepared as described above. Aliquots (300 ml) of suspensions containing 5 Â 10 8 spheroplasts were incubated with and without 5 mM AMS at 30 C for 4 min. LolA (20 mg) was added to each suspension, followed by incubation at 30 C for 1 min. M63 medium (750 ml), containing 0.25 M sucrose and 370 kBq of Tran 35 S-label, was then added to label L10P for 2 min, followed by the addition of nonradioactive Met and Cys (each at 12 mM) to chase the labeling for 2 min. The release of L10P was terminated by chilling the reaction mixture on ice, and then spheroplasts and medium were separated by centrifugation at 16;000 Â g for 2 min. After solubilization of the spheroplasts with 50 mM Tris-HCl, pH 7.5, containing 0.1% SDS and 2% Triton X-100, each fraction was immunoprecipitated with anti-Lpp antibody, and then the radiolabeled L10P was analyzed by SDS-PAGE and phosphorimaging.
Other techniques. SDS-PAGE was carried out as described previously, 28) except that an HI gel 29) was used in the analysis of Lpp. The proteins separated on SDS-PAGE were transferred to polyvinylidene fluoride membranes, and then the blots were developed with an enhanced chemiluminescence substrate (ECL-Plus, GE Healthcare), followed by detection with a lumino-image analyzer (LAS-1000plus, Fujifilm, Tokyo).
Results
Membrane topologies of LolC and LolE
Various programs have been reported for prediction of the topologies of membrane proteins. HMMTOP, 30) TMpred, 31) DAS, 32) and SOSUI 33) predicted that both LolC and LolE have a large region, comprising more than 200 residues, exposed to the periplasm, and flanked by TMS-1 and TMS-2. The four programs predicted essentially the same membrane topology for LolE, one having four TMSs (Fig. 1A) . On the other hand, the C-terminal membrane topology of LolC predicted by the first two programs was considerably different from that predicted by the other two. For example, SOSUI predicted a slightly different region for TMS-4, and DAS predicted an additional TMS between TMS-3 and TMS-4. The differing predictions appeared to be caused by the highly hydrophobic property of the C-terminal region of LolC (Fig. 1B) .
To examine the membrane topology, PhoA was fused at various positions of LolC and LolE. PhoA exhibits low activity when localized in the cytoplasm, whereas it exhibits high activity in the periplasm.
34) The C-terminal region was examined in detail, since the predicted topology of LolC was different. LolC and LolE exhibit 26% sequence identity, and PhoA was fused to 14 residues conserved between LolC and LolE (Table 1) . Plasmids encoding these fusions were introduced into E. coli DLP79-36, and expression of the fusion proteins was induced by the addition of arabinose. Fusion of PhoA to L371 and V380 of LolE generated unstable derivatives ( Table 1 ), suggesting that the major part of TMS-4 should be expressed for stable expression of LolE. But the lower expression of these PhoA fusions did not affect the interpretation of the results, as discussed below.
The LolC-PhoA fusions exhibited high activities when PhoA was fused to L60, G159, and M262, indicating that these positions are localized on the periplasmic side of the inner membrane (Fig. 2) . In contrast, PhoA fused to K293, I310, G318, G325, and G333 of LolC exhibited lower activities. Therefore, LolC has the first large periplasmic loop encompassing L60 through M262, which is flanked by TMS-1 and TMS-2. The PhoA activities suggested that the region from L340 to I347 is exposed to the periplasm, while that from L356 to the C-terminus spans the membrane once and exposes the C-terminus to the cytoplasm. These results indicate that LolC spans the membrane 4 times, not 5 times, contrary to the prediction by DAS.
PhoA fused to L60, G163, M267, G338, L345, and I352 of LolE exhibited high activity, while that fused to K298, I315, and G323 exhibited low activity (Fig. 2) . Therefore, LolE has the first large periplasmic loop encompassing L60 through M267. Judging from the high PhoA activities and levels of expression (Table 1) , the region encompassing G330 through I352 appeared to be the second short periplasmic loop but all four programs predicted G330 is located in the middle of TMS-3 (Fig. 1) . If G330 were exposed to the periplasm, TMS-3 would be too short to span the membrane. Hence we speculate that G330 is located in the membrane and that PhoA fused to it is exposed to the periplasm. The second periplasmic loop therefore encompasses L338 through I352. The PhoA activities indicated that the C-terminal region from L371 through A402 of LolE spans the membrane once and exposes the C-terminus to the cytoplasm.
Accessibility of Cys introduced into the periplasmic regions of LolC and LolE
E. coli CDE4 (ÁlolCDE) harboring pMAN1015 cannot grow at 42 C, since the plasmid carries a temperature-sensitive replicon together with the genes for essential LolCDE. 12) On the other hand, CDE4 harboring pAICDE, which carries lolCDE under the control of the araBAD promoter and the p15A replicon, grew even after pMAN1015 had been deleted at 42 C. A derivative of pAICDE, pCYSE0, encodes LolC, LolD, and Cys-less LolE. This plasmid also supported the growth of CDE4 at 42 C, indicating that Cys-less LolE is functional. Neither LolC nor LolE expressed from this plasmid therefore contains Cys. To examine the structures and functions of periplasmic regions, a single Cys was introduced into the corresponding positions in the first and second periplasmic loops of LolC and LolE. All 20 pCYSE0 derivatives thus constructed supported the growth of CDE4, indicating that the Cys mutants of LolC and LolE are functional. CDE4 cells were transformed with one of the pCYSE0 derivatives and pMYL10P encoding L10P, which is a derivative of the major outer membrane lipoprotein Lpp and a suitable substrate for examination of the release from spheroplasts. 23) All the transformants except one harboring the pCYSE0 derivative encoding LolCDE(G338C) grew even when L10P was expressed. CDE4 cells expressing LolCDE(G338C) grew only when expression of L10P from the lac promoter was inhibited by the addition of 0.2% glucose. It is known that the defect in the lipoprotein transfer pathway is severer in cells expressing Lpp, because mislocalized Lpp forms a lethal covalent linkage with peptidoglycan. 20) These results indicate that LolE(G338C) is defective but supports the growth of CDE4 because the strain lacks Lpp. Nineteen other derivatives were used in further analysis.
CDE4 cells expressing the LolCDE complex containing one of the 19 Cys derivatives of LolC and LolE were converted into spheroplasts and treated with 14 C-NEM, a membrane-permeable sulfhydryl reagent, with and without pre-treatment with AMS (mol. mass ¼ 536 Da), a membrane-impermeable reagent, and their crude membrane fractions were analyzed by SDS-PAGE and fluorography (Fig. 3) . When the cells were not pretreated with AMS, all the LolC derivatives except for LolC(L356C) were labeled with 14 C-NEM (Fig. 3A) . It is known that NEM covalently modifies the Cys present in an aqueous environment, but not in membranes. 35) Since the expression level of LolC(L356C) was moderate, we assume that Cys at this position is in the membrane. Likewise, three of the nine LolE derivatives, L187C, I352C, and V380C, were not labeled with 14 C-NEM even before AMS treatment. Since PhoA fused to V380 exhibited low activity, we concluded that V380 is present in the membrane (Fig. 2) . The reason L187 and I352 of LolE were not labeled with 14 C-NEM is discussed below.
Next we examined to determine whether the labeling of Cys with 14 C-NEM is inhibited by prior treatment with AMS. The labeling of four LolC derivatives, L60C, L125C, G159C, and L183C, having Cys in the first periplasmic loop was significantly inhibited, whereas the labeling of the other LolC derivatives mostly having Cys in the second periplasmic loop was only marginally inhibited by prior treatment with AMS (Fig. 3B) , indicating that the first but not the second periplasmic loop of LolC is accessible to AMS. In contrast to LolC derivatives, only two LolE derivatives, G163C and L361C, were accessible to AMS. The labeling of the other LolE derivatives was hardly inhibited by prior treatment with AMS. These results taken together suggest that the structure of the periplasmic region is different between LolC and LolE. For example, L183C of LolC is sensitive to both NEM and AMS, whereas L187C present at the corresponding position of LolE was not labeled with NEM at all, suggesting that L187 of LolE is present inside the folded periplasmic loop. PhoA fused to I352 of LolE exhibited high activity, but I352C was not labeled with 14 C-NEM. It is possible that I352 of LolE is embedded in the membrane, while PhoA fused at this position is exposed to the periplasm because the fusion protein lacks the C-terminal region (Fig. 2) .
Since the inhibition of 14 C-NEM-labeling by AMS strongly indicates exposure of Cys to the periplasm, it is concluded that L361 of LolE is located in the periplasm (Fig. 2) .
Effect of AMS modification of Cys on lipoprotein release
Next we examined the effect of Cys modification with a sulfhydryl reagent on LolA-dependent L10P release. However, when spheroplasts prepared from CDE4 cells were treated with NEM, labeling of L10P was completely blocked. Hence we treated spheroplasts expressing Cys mutants of LolC or LolE with AMS, which did not inhibit L10P labeling in the spheroplasts. AMS had no effect on LolA-dependent L10P release from spheroplasts expressing Cys-less LolCDE (Fig. 4A) . We selected three pairs of LolC and LolE derivatives having Cys at the corresponding positions. Both LolC(G159C) and LolE(G163C) were accessible to AMS (Fig. 3) but AMS treatment of CDE4 cells expressing these Cys derivatives hardly affected L10P release from the spheroplasts (Fig. 4B) , indicating that AMS (mol. mass ¼ 536 Da) introduced into the middle of the first periplasmic loop does not cause any steric hindrance. The lipoprotein release activity of spheroplasts expressing LolC(L183C) was nearly completely inhibited by AMS treatment whereas that of the spheroplasts expressing LolE(L187C) was hardly inhibited (Fig. 4B) , because the latter were probably not accessible to AMS as well as they were to NEM (Fig. 3) . AMS was accessible to LolE(L361C) and severely inhibited L10P release. On the contrary, AMS did not affect L10P release from the spheroplasts expressing LolC(L356C). As speculated above, Cys at 356 of LolC might be located in the membrane (Fig. 3) .
Discussion
Although LolC, LolD, and LolE are essential for the growth of E. coli, 12) LolC was dispensable for the reconstituted lipoprotein-releasing activity in proteoliposomes. 13) In contrast, LolA was found to interact directly with LolC but not with LolE. 14) Based on these observations, we speculated that LolC and LolE Spheroplasts prepared from CDE4 cells were treated with and without AMS as described in Fig. 3 and then subjected to L10P release assay in the presence and the absence of 20 mg/ml LolA, as described under ''Materials and methods.'' 35 S-labeled L10P in spheroplasts (p) and spheroplast supernatant (s) were analyzed by SDS-PAGE and phosphorimaging. A, spheroplasts expressing Cysless LolCDE were examined as a control. B, three pairs of LolC and LolE derivatives having Cys at the corresponding positions were examined. The amounts of L10P released into the spheroplast supernatants were determined as in Fig. 3B , and were expressed as percentages, taking the total amount of L10P as 100.
function distinctly in the lipoprotein release reaction. We thought that the periplasmic regions might be responsible for the functional differentiation between LolC and LolE. The large periplasmic region flanked by TMS-1 and TMS-2 is characteristic of the membrane subunits of ABC transporters having four TMSs, 15) suggesting that this region plays an important role in the various functions of this class of ABC transporters. The results reported here indicate that not only the first but also the second periplasmic regions of LolC and LolE are functionally important and are different in their local structures.
Okuda and Tokuda 14) recently reported that the periplasmic regions of both LolC and LolE exhibit approximately 16% sequence identity with that of LolB, and they speculated that they might have a similar LolA/LolB fold with an incomplete -barrel structure. 36) Lipoprotein transfer was found to occur from the entrance of the hydrophobic cavity of LolA to that of LolB in a mouth-to-mouth mode. 14) Because LolA interacts with LolC but not LolE, it has ben proposed that lipoproteins are transferred from LolE to LolC in the LolCDE complex also in a mouth-to mouth mode. 14) To determine how the differences in the local structures of the periplasmic loops of LolC and LolE contribute to unidirectional transfer of lipoproteins, the threedimensional structures of the periplasmic loops must be clarified.
Four programs predicted essentially the same membrane topology for LolE, whereas the C-terminal half of LolC was differently predicted by SOSUI and DAS. Based on the PhoA fusion data, we concluded that LolC also has four TMSs. In contrast, DAS predicted another TMS between TMS-3 and -4 (Fig. 1A) . This extra TMS comprised seven (potential, 346-352) to 14 (less potential, 343-356) amino acid residues. Since PhoA fused to I347 of LolC exhibited high PhoA activity (Table 1) , this region is unlikely to span the membrane. Moreover, PhoA fused to the C-terminal region did not exhibit high activity, indicating that the extra TMS causing periplasmic exposure of the Cterminus is unlikely. LolC(I347C) was labeled with NEM but not AMS (Fig. 3A) , suggesting that the region containing I347C forms a folded structure and is thus inaccessible to AMS. Alignment of the LolC and LolE sequences (Fig. 1A) indicated that the difference in chain length between the two proteins is largely due to the second periplasmic region. These results taken together indicate that the difference in the structures of LolC and LolE is most significant in the C-terminal half.
